Keyphrases
IL-24
100%
Melanoma
100%
Cancer-specific
100%
Apoptosis-inducing Activity
100%
Adenovirus
28%
Associated Genes
28%
Differentiation Therapy
28%
Interferon-α (IFN-α)
14%
Tumor
14%
Growth Control
14%
Apoptosis
14%
Clinically Significant
14%
Gene Therapy
14%
Tumor Cells
14%
Fibroblasts
14%
Phase I Clinical Trial
14%
Melanoma Differentiation-associated gene-7
14%
Induced Apoptosis
14%
Tumor Angiogenesis
14%
Less Toxic
14%
Interleukin-10 Gene
14%
Treatment Paradigms
14%
Regulatory Activity
14%
Gene Family
14%
Immune Regulation
14%
Programmed Cell Death
14%
Molecular Approaches
14%
Chromosomal Location
14%
Intratumoral Injection
14%
Inhibit Tumor
14%
Lethality
14%
Conserved Structures
14%
Senescence
14%
Human Melanoma Cells
14%
Cancer Growth
14%
Antitumor Therapy
14%
No Toxicity
14%
Focus of Attention
14%
Suppression Subtractive Hybridization
14%
Bystander Antitumor Activity
14%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Interleukin 24
100%
Programmed Cell Death
100%
Adenoviridae
33%
Immunity
33%
Growth Regulation
16%
Clinical Trial
16%
Antineoplastic Activity
16%
Gene Therapy
16%
Transfection
16%
Cell Death
16%
Angiogenesis
16%
Multigene Family
16%
Animal Model
16%
Chromosome Structure
16%
Interleukin 10
16%
Interferon
16%
Fibroblast
16%
Immunology and Microbiology
Cytokine
100%
Interleukin 24
100%
Programmed Cell Death
100%
Immunity
33%
Adenoviridae
33%
Tumor Cell
16%
Genetic Transfection
16%
Cell Death
16%
Angiogenesis
16%
Antineoplastic Activity
16%
Growth Regulation
16%
Interleukin 10
16%
Melanoma Cell
16%
Chromosome Structure
16%
Multigene Family
16%
Beta Interferon
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cytokine
100%
Melanoma
100%
Interleukin 24
100%
Neoplasm
33%
Adenoviridae
22%
Lethality
11%
Clinical Trial
11%
Cancer Growth
11%
Antitumor Activity
11%
Interleukin 10
11%
Programmed Cell Death
11%
Beta Interferon
11%
Mezerein
11%